Acquisition by Walts Alan Edmund of 2859 shares of Eloxx Pharmaceuticals subject to Rule 16b-3
| ELOXDelisted Stock | USD 6.12 0.30 4.67% |
Slightly above 61% of Eloxx Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Eloxx Pharmaceuticals pink sheet suggests that many investors are alarmed at this time. Eloxx Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Eloxx Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Eloxx |
Filed transaction by Eloxx Pharmaceuticals Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Eloxx Pharmaceuticals Fundamental Analysis
We analyze Eloxx Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eloxx Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eloxx Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
Eloxx Pharmaceuticals is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Eloxx Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eloxx Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Eloxx Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Eloxx Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Eloxx Pharmaceuticals Related Equities
| IMMX | Immix Biopharma | 19.39 | ||||
| UNCY | Unicycive Therapeutics | 15.25 | ||||
| WINT | Windtree Therapeutics | 8.93 | ||||
| CYTO | Altamira Therapeutics | 7.50 | ||||
| ENVB | Enveric Biosciences | 3.13 | ||||
| RVPH | Reviva Pharmaceuticals | 1.79 | ||||
| PALI | Palisade Bio | 0.83 | ||||
| ZURA | Zura Bio | 0.33 | ||||
| ELEV | Elevation Oncology | 1.59 | ||||
| ZVSA | ZyVersa Therapeutics | 3.60 | ||||
| CNSP | Cns Pharmaceuticals | 7.69 | ||||
| ALLR | Allarity Therapeutics | 10.48 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Eloxx Pink Sheet
If you are still planning to invest in Eloxx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eloxx Pharmaceuticals' history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |